Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis
NCT06501378
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Interventions
DRUG:
PD-1/PD-L1 inhibitor plus chemotherapy
RADIATION:
SRT/WBRT
Sponsor
Fudan University